RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA considers adding a dozen peptides to its bulk drug compounding list RAPS The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Erectile Dysfunction: Exploring the Peptide's Potential Role